Knockdown of A-kinase anchor protein 4 inhibits proliferation of triple-negative breast cancer cells and
Triple-negative breast cancers are the most aggressive subtypes with poor prognosis due to lack of targeted cancer therapy. Recently, we reported an association of A-kinase anchor protein 4 expression with various clinico-pathological parameters of breast cancer patients. In this context, we examine...
Main Authors: | Nirmala Jagadish, Sonika Devi, Namita Gupta, Vitusha Suri, Anil Suri |
---|---|
Format: | Article |
Language: | English |
Published: |
IOS Press
2020-04-01
|
Series: | Tumor Biology |
Online Access: | https://doi.org/10.1177/1010428320914477 |
Similar Items
-
A novel cancer testis antigen, A-kinase anchor protein 4 (AKAP4) is a potential biomarker for breast cancer.
by: Shikha Saini, et al.
Published: (2013-01-01) -
Sperm associated antigen 9 (SPAG9) a promising therapeutic target of ovarian carcinoma
by: Nirmala Jagadish, et al.
Published: (2018-05-01) -
Protein kinase C inhibitor chelerythrine selectively inhibits proliferation of triple-negative breast cancer cells
by: Wanjun Lin, et al.
Published: (2017-05-01) -
Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling
by: Pradip Shahi Thakuri, et al.
Published: (2020-01-01) -
Cepharanthine sensitizes triple-negative breast cancer cells to doxorubicin and inhibits cell proliferation
by: ZHANG Yanhao, et al.
Published: (2019-11-01)